Gene therapy shows promise for treating Niemann-Pick disease type C1
For the first time, NIH researchers have demonstrated in mice that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1. The study was published in the journal Human Molecular Genetics. October 26, 2016